Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A healthier diet and reduced waist-to-hip ratio during midlife are linked to improved brain and cognitive health in later years, longitudinal findings from the Whitehall II cohort study show.

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested the latest economic data and Trump's response to Canada and EU tariffs. The S&P 500 closed in correction territory.

A new screening intervention in the primary care setting can improve the identification and management of obesity risk in pediatric patients, according to a poster presented at the National ...

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

Recent discussions have emerged challenging the traditional reliance on BMI for diagnosing obesity, advocating for a more precise approach that considers individual health factors.

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

Not necessarily — but it’s complicated. For years, body size was considered a barrier to most sports, but today that’s ...

Nearly 40% of consumers classified as overweight or obese under traditional body mass index (BMI) definitions would no longer carry that diagnosis under newly proposed criteria recently published ...

The obesity diagnosis has always been controversial. Now, a new clinical definition is raising even more questions.